] i accumulation and prevented the myocytes from developing hypercontracture. In whole-cell recording studies, H 2 O 2 significantly enhanced the late Na + current (I Na,L ) and L-type Ca 2+ current (I Ca,L ) in myocytes, which were dramatically suppressed or prevented by resveratrol. Furthermore, H 2 O 2 -induced ROS production and CaMKII activation were significantly prevented by resveratrol. Conclusion: Resveratrol protects ventricular myocytes against oxidative stress-induced arrhythmogenic activity and Ca 2+ overload through inhibition of I Na,L /I Ca,L , reduction of ROS generation, and prevention of CaMKII activation.
Introduction
Reactive oxygen species (ROS) are increasingly generated under various pathological conditions, such as ischemia/reperfusion, myocardial infarction, and heart failure. Increased oxidative stress causes a series of detrimental effects on the heart [1] . Hydrogen peroxide (H 2 O 2 ), which can cause oxidative stress, is significantly elevated in hearts exposed to ischemia/reperfusion and predisposes the heart to ischemia/ reperfusion injury and arrhythmias. In myocardial infarction, increasing ROS contribute to left ventricular remodeling and arrhythmias [1, 2] . Increased oxidative stress is also associated with reduced left ventricular function in heart failure [3] . The underlying mechanisms may involve an impairment of Na and Ca homeostasis [4, 5] , which subsequently causes mechanical dysfunction, arrhythmias and even cell death [6] . Recently, Ca/calmodulin-dependent protein kinase II (CaMKII) has been suggested to be an important mediator of ROS-induced detrimental effects [6, 7] . ROS activates CaMKII via autophosphorylation-and oxidation-dependent mechanisms [8] , which in turn enhance late sodium current (I Na,L ) and L-type calcium current (I Ca,L ) in cardiac myocytes [6, 9] . Augmentation of I Na,L and I Ca,L not only causes a prolongation of action potential duration (APD) and the occurrence of early afterdepolarizations (EADs) but also leads to sodium and calcium overload, contractile dysfunction, the occurrence of delayed afterdepolarizations (DADs) and triggered activities [6, 7, 10] . Despite the serious detrimental effects caused by increased oxidative stress in structural heart diseases, few drugs exist that can be used for clinical treatment.
Resveratrol (trans-3,4',5-trihydroxystilbene) is a natural compound found in abundance in grapes, mulberries, peanuts and red wine [11] . Over the past two decades, it has been demonstrated from both in vitro and in vivo studies to have cardioprotective effects, including anti-inflammatory, antioxidative, and anti-hyperlipidemic properties as well as the prevention of platelet aggregation and cardiac hypertrophy [12] [13] [14] . These beneficial effects of resveratrol may provide explanations for the "French paradox", the finding that the consumption of red wine is associated with a decreased incidence of cardiovascular diseases [15] . Recently, studies have revealed that resveratrol can reduce ventricular arrhythmias in myocardial infarction [2, 16] , ischemia/reperfusion [17] , heart failure and other pathological conditions [18] . Accumulating evidence indicates that increased oxidative stress is an important factor predisposing the diseased heart to calcium overload and lethal arrhythmias [6, 7, 10] . However, it is unclear whether resveratrol has protective effects against oxidative stress-induced arrhythmias. Therefore, the present study aims to investigate the effects of resveratrol on exogenous H 2 O 2 -induced arrhythmogenic activity and calcium overload and explore the underlying mechanisms.
Materials and methods

Animals
Six-month-old New Zealand White male rabbits weighing 2.0 to 3.0 kg were used for experiments. Animal care and handling procedures were approved by the Animal Care and Use Committee, Research Institute of Medicine, Shanghai Jiao Tong University, in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institute of Health (NIH Publication No 85-23, revised 1996). Materials H 2 O 2 and resveratrol were purchased from Sigma Chemical (St Louis, MO, USA). Resveratrol was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution of 50 mmol/L with the final concentration of DMSO at less than 0.1%. The same amount of DMSO was added to all groups to exclude the effects of DMSO on myocytes. All experiments were performed at a temperature of 25±1 °C, unless otherwise mentioned.
Cell isolation
Ventricular myocytes were enzymatically isolated from the hearts of New Zealand White rabbits as previously described [10] .
Measurement of cellular arrhythmias
Ca 2+ transients and cell shortening were simultaneously detected as previously described [19] . Freshly isolated rabbit ventricular myocytes were incubated with a Ca 2+ indicator, Fura-2 AM (2 μmol/L; Molecular Probes, Carlsbad, CA, USA), at 25 °C for 10 min. Loaded cells were electrically stimulated at a pacing cycle length (PCL) of 6 s or 2 s. Cell shortening was continuously monitored and Ca 2+ transients were recorded every 3 min or when the cellular arrhythmias emerged. Cellular arrhythmias were induced upon addition of H 2 O 2 (200 μmol/L). It is generally accepted that after-contractions and after-transients were defined as cellular proarrhythmogenic events, in which early after-transients/contractions (EATs/ EACs) may correspond to EADs and delayed after-transients/ contractions (DATs/DACs) may correspond to DADs [7, [20] [21] [22] [23] . Therefore, EATs/EACs and DATs/DACs can be used as proximal direct indices of EADs-like and DADs-like arrhythmias, respectively. The probabilities of EATs/EACs occurrence were assessed by calculating the percentage of calcium transients or cell shortenings that developed EATs/EACs within 1 min after the treatments (H 2 O 2 and resveratrol) reached steady state. The calcium transient duration (CaTD) was measured as the time from the upstroke to 80% recovery (ie, CaTD 80 ).
Measurement of [Ca
2+ ] i and cell shortening Myocytes were paced at a frequency of 0.5 Hz (PCL=2 s). The ratio of emitted fluorescence at 340 and 380 nm was recorded as an indicator of [Ca 2+ ] i . Cell shortening was detected using an optical edge detector and collected using a charge-coupled device camera (IonOptix; Milton, MA, USA). The data were analyzed using IonWizard 6.0 software (IonOptix; Milton, MA, USA).
Electrophysiological study
Whole cell currents (I Na,L , I Ca,L ) were recorded under voltage clamp mode with an EPC10 amplifier (Heka Electronic, Lambrecht, Pfalz, Germany) as previously described [10, 24] . Current signals were filtered at 1 kHz and digitized at 10 kHz. For I Na,L recording, pipettes were filled with an internal solution containing (in mmol/L): 120 CsCl 2 , 1.0 CaCl 2 , 5 MgCl 2 , 5 Na 2 ATP, 10 TEACl, 11 EGTA, and 10 HEPES (pH 7.2, adjusted with CsOH). Myocytes were bathed with a modified Tyrode's solution containing (in mmol/L): 135 NaCl, 5.4 CsCl 2 , 1.8 CaCl 2 , 1 MgCl 2 , 0.3 BaCl 2 , 0.33 NaH 2 PO 4 , 10 glucose, 10 HEPES, and 0.001 nicardipine at pH 7.3. I Na,L was elicited by 300 ms depolarizing pulses from -120 to -20 mV at a PCL of 6 s. The amplitude of I Na,L was measured at 200 ms after the initiation of the depolarization step.
To record I Ca,L , patch pipettes were filled with an internal solution containing (in mmol/L): 110 Cs-Aspartate, 30 CsCl, 5 NaCl, 10 HEPES, 0.1 EGTA, 5 MgATP at pH 7.2 adjusted with CsOH, and the cells were superfused with a modified Tyrode's solution in which KCl was replaced with CsCl. To inactivate the Na + current, the myocytes were stimulated by a 100 ms prepulse to -40 mV from the holding potential of -80 mV. Subsequently, I Ca,L was elicited by a test depolarization step to 0 mV for 300 ms. The current density was calculated by dividing the amplitude by the cell capacitance. 
Protein preparation and Western blotting
After intravenous anesthetization with sodium pentobarbital (30 mg/kg), rabbit hearts were immediately removed and mounted on a Langendorff apparatus and retrogradely perfused through the aorta (30 mL/min) with specific solutions depending on the condition for 10 min at 37 °C: Tyrode's solution containing vehicle, Tyrode's solution containing 200 μmol/L H 2 O 2 and vehicle, and Tyrode's solution containing 200 μmol/L H 2 O 2 and 50 μmol/L resveratrol. The left ventricular tissue was then isolated and flash frozen in liquid nitrogen. Protein preparations were performed using methods as described previously [25] and the protein contents of CaMKII (antiphospho-CaMKII, 1:1000, Abcam, Cambridge, UK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1:1000, Beyotime, Haimen, China) in total protein preparations were analyzed by standard Western blotting.
Statistical analysis
The data are expressed as the mean±SEM. Statistical significance was assessed using Student's t-tests or ANOVA analysis followed by the Student-Newman-Keuls test. The frequencies of arrhythmia were compared using a chi-squared test. P<0.05 was considered statistically significant.
Results
Resveratrol suppressed and prevented H 2 O 2 -induced arrhythmogenic activity in rabbit ventricular myocytes Cell shortening and calcium transients were simultaneously recorded from isolated rabbit ventricular myocytes. To stably induce EAD-like arrhythmias, the myocytes were paced at a low frequency (0.16 Hz, PCL=6 s) as previously described [7] . After reaching steady state, the myocytes were continuously perfused with 200 μmol/L H 2 O 2 . As shown in Figure 1A, Figure 1B ). As summarized in Figure 1D , the probability of EATs/EACs occurrence was significantly reduced by resveratrol at both 50 and 30 μmol/L, in a dose-dependent manner (92%±2.8% vs 36%±1.2% and 6%±0.8%, P<0.05 and P<0.01, respectively). Accordingly, the CaTD 80 prolongation induced by H 2 O 2 was also attenuated by resveratrol. The CaTD 80 was increased by H 2 O 2 from 1055±72 to 1892±154 ms; resveratrol (50 μmol/L) decreased the CaTD 80 to 1340±116 ms and attenuated by 55%±11% the prolongation of CaTD caused by H 2 O 2 (P<0.05, n=8 cells from 4 rabbits).
Co-treatment of myocytes with resveratrol (50 μmol/L) blunted the prolongation of CaTD caused by H 2 O 2 and significantly prevented the induction of EATs/EACs ( Figure  1C ). Although resveratrol could not completely prevent the induction of H 2 O 2 -induced EATs/EACs, it markedly delayed the time for the development of EATs/EACs from 7.4±0.5 min (H 2 O 2 group) to 31±3 min (P<0.01, n=8 cells from 5 rabbits) ( Figure 1E ). In addition to preventing the induction of EATs/ EACs caused by H 2 O 2 , resveratrol also prevented the myocytes from developing DATs/DACs ( Figure 1C) Figure 3B ).
Consistent with this finding, resveratrol prevented hypercontracture caused by H 2 O 2 . As shown in Figure 3C , H 2 O 2 -induced calcium overload led to the development of hypercontracture, which is a permanent reduction (<50%) of the longitudinal cell length attributable to a persistent activation of myofilaments [6] . H 2 O 2 caused the development of hypercontracture within 21±1.3 min (n=43 cells from 10 rabbits). However, in the presence of resveratrol, myocytes (n=22 cells from 8 rabbits) exposed to H 2 O 2 never developed hypercontracture within 40 min. A Kaplan-Meier survival analysis ( Figure 3D ) revealed that resveratrol effectively prevented ROS-induced hypercontracture and cell death. Resveratrol inhibited ROS-induced I Na,L augmentation It has been reported previously [6, 7, 10] that augmentation of I Na,L plays a key role in ROS-induced cellular Na + and Ca 2+ overload and arrhythmias. Therefore, we first examined whether resveratrol could inhibit ROS-induced I Na,L augmentation. When myocytes were exposed to H 2 O 2 , I Na,L gradually increased in a time-dependent manner and reached a steady state at approximately 10-14 min after H 2 O 2 treatment. Treatment with resveratrol markedly prevented the time-dependent increase of I Na,L induced by H 2 O 2 ( Figure 4A ). At the point of 12 min after H 2 O 2 exposure, I Na,L increased from -0.31±0.014 pA/pF to -1.06±0.037 pA/pF in the H 2 O 2 group, increased by 245%±23% (n=6 cells from 4 rabbits). While in the resveratrol treatment group, I Na,L increased from -0.31±0.032 pA/pF to -0.53±0.028 pA/pF, only a 75%±11% increase of I Na,L (n=6 cells from 4 rabbits, P<0.01, Figure 4B ). Resveratrol also reversed the H 2 O 2 -induced I Na,L augmentation ( Figure 4C ). I Na,L increased from -0.31±0.013 pA/pF to -1.07±0.045 pA/pF after the incubation of myocytes with H 2 O 2 (P<0.05, n=6 cells from 5 rabbits). The addition of resveratrol reduced the current to -0.53±0.031 pA/pF in the presence of H 2 O 2 (P<0.05; Figure 4D ), a 178%±17% decrease of the H 2 O 2 -induced I Na,L .
Resveratrol inhibited ROS-induced I Ca,L augmentation
Because reactivation of I Ca,L contributes to the H 2 O 2 -induced EAD in rabbit ventricular myocytes [7] , we next investigated the potential involvement of I Ca,L in the inhibitory effect of resveratrol on H 2 O 2 -induced EATs/EACs. As shown in Figures 5A and 5B, H 2 O 2 increased I Ca,L from -8.2±0.8 pA/pF to -12.3±1.4 pA/pF (P<0.05, n=6 cells from 4 rabbits) and resveratrol reduced the current to -9.1±0.8 pA/pF (P<0.05), indicating that resveratrol markedly inhibited H 2 O 2 -induced I Ca,L augmentation.
Resveratrol reduced H 2 O 2 -induced ROS production
To determine whether resveratrol inhibits the arrhythmogenic activity and calcium overload via decreasing intracellular ROS, the effect of resveratrol on intracellular ROS levels was measured. ROS production was monitored by detecting the fluorescence from the reaction of intracellular ROS with C-DCDHF-DA using fluorescence microscopy. As shown in Figures 6A and 6B , DCF fluorescence intensity was signifi- 
Resveratrol prevented H 2 O 2 -induced CaMKII activation
It has been reported that ROS can markedly activate CaMKII [6] . Having confirmed that resveratrol reduced ROS production, we next tested whether ROS-induced CaMKII activation could be prevented by resveratrol. Using a CaMKII assay kit, we found that H 2 O 2 (200 μmol/L) effectively increased CaMKII activity and resveratrol (50 μmol/L) significantly prevented this activation in isolated myocytes (P<0.05 vs H 2 O 2 group; Figure 7A ). With a Western blotting analysis using the antibody against p-CaMKII, we further confirmed that resveratrol prevented H 2 O 2 -induced CaMKII activation. As shown in Figures 7B and 7C , CaMKII phosphorylation was significantly increased in hearts perfused with 200 μmol/L H 2 O 2 for 10 min (P<0.05 vs control), and resveratrol decreased the activation of CaMKII (P<0.05 vs H 2 O 2 group).
Discussion
The cardioprotective effects of resveratrol are complex and are not completely understood. In the present study, we provide the first evidence showing that resveratrol prevents and suppresses oxidative stress-induced arrhythmogenic activity. It also prevents oxidative stress-induced calcium overload and cell death. Furthermore, our study suggests that the underlying mechanisms involve: (1) inhibition of I Na,L /I Ca,L ; (2) reduction of ROS generation; and (3) prevention of CaMKII activation.
EAD-mediated triggered activity plays an important role in ROS-induced arrhythmias [26] . In this study, we observed that resveratrol significantly suppressed and prevented H 2 O 2 -induced EATs/EACs, ie, EAD-like arrhythmias. At 0.16 Hz (PCL 6 s), resveratrol markedly delayed the time to develop EATs/EACs. It also reversed H 2 O 2 -induced EATs/ EACs when added after EATs/EACs were induced. Recent studies [7, 10] have implicated that ROS-activated CaMKII mediates EAD formation. Downstream targets of ROS include CaMKII, I Ca,L , and I Na,L . ROS-activated CaMKII causes I Ca,L and I Na,L augmentation through the regulation of calcium and sodium channel phosphorylation sites [27] . Xie et al [7, 10] have demonstrated that both I Ca,L and I Na,L are required for ROSinduced EAD formation: activation of late I Na to reduce the repolarization reserve (ie, to prolong APD) and the modification of I Ca,L to enhance its reactivation properties to generate the EAD upstroke. In the present study, we found that resveratrol effectively reduced H 2 O 2 -induced ROS generation. With a CaMKII assay kit, we showed that resveratrol significantly prevented H 2 O 2 -induced CaMKII activation in isolated myocytes. Using CaMKII phosphorylation at threonine-287 as a marker of CaMKII activity, we further confirmed that resvera- [16, 28] have reported that resveratrol can directly modulate ion channels. For instance, resveratrol can inhibit I Ca,L and enhance the ATP-sensitive potassium current (I K,ATP ) in isolated ventricular myocytes [16] . It can also inhibit the sodium current (I Na ), transient (I to ) and sustain (I ss ) outward potassium currents [17] . Therefore, we cannot rule out the possibility that a direct inhibition of I Na,L and I Ca,L by resveratrol contributes to its inhibition of EATs/EACs. Interestingly, when myocytes were paced at a higher frequency (0.5 Hz, at a PCL of 2 s), resveratrol completely prevented the H 2 O 2 -induced EATs/EACs for at least 40 min, indicating that resveratrol has enhanced anti-arrhythmias properties at a higher frequency. This may be due to a larger I Na,L at lower frequencies [24, 29] , which makes myocytes more prone to EATs/EACs. In sinus rhythm, I Na,L is much smaller than it is at 0.16 Hz. Thus, resveratrol may be expected to be more effective in preventing H 2 O 2 -induced EATs/EACs under sinus rhythm.
Calcium overload is an important factor causing DADinduced arrhythmias and cell death [6] . In this study, we showed that resveratrol significantly blunted time-dependent [Ca 2+ ] i increase induced by H 2 O 2 . As a result, resveratrol prevented H 2 O 2 -induced hypercontracture and cell death. Accordingly, resveratrol completely prevented the development of DATs/DACs, the DAD-like arrhythmias. Recent studies indicate that CaMKII activation and I Na,L augmentation play important roles in the ROS-induced Ca 2+ overload and arrhythmias [4] . Under various cardiac pathological conditions, there exists a lethal cycle between CaMKII and I Na,L [30, 31] . ROS dramatically enhances I Na,L via CaMKII activation; the enhanced I Na,L further activates CaMKII, leading to CaMKII over-activation [6, 30] . Consequently, on the one hand, the ROSinduced over-activation of CaMKII phosphorylates RyR2 and causes sarcoplasmic reticulum (SR) calcium leak [32] ; on the other hand, the CaMKII activation-enhanced I Na,L leads to sodium overload and subsequently calcium overload via the NCX [4] . Calcium overload and SR calcium leak always induce arrhythmogenic calcium wave and cause DAD-like arrhythmias [22] . Additionally, calcium overload leads to the development of hypercontracture and cell death [6] . Therefore, elevated ROS leads to the development of a lethal cycle between CaMKII and I Na,L in diseased hearts. In the present study, we showed that resveratrol prevented H 2 O 2 -induced CaMKII activation and augmentation of I Na,L , and effectively blocked the lethal cycle between them. Thus, resveratrol prevented the H 2 O 2 -induced calcium overload and DAD-like arrhythmias. In addition, ROS can directly oxidize RyR2 [33] , leading to an increased calcium spark, DAD-like arrhythmias and calcium overload. By reducing ROS generation, resveratrol may reduce RyR2 oxidization and also suppress DAD-like arrhythmias and calcium overload.
A limitation of the present study was that we did not investigate the anti-arrhythmias properties of resveratrol at the organ/whole heart level. This requires further study in the future.
In conclusion, resveratrol significantly suppressed and prevented oxidative stress-induced arrhythmogenic activity and calcium overload by inhibition of I Na,L /I Ca,L , reduction of ROS 
